These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28928704)
21. Associations of depressive symptoms with white matter abnormalities and regional cerebral blood flow in patients with amnestic mild cognitive impairment. Hirao K; Yamashita F; Kato H; Kaneshiro K; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S Geriatr Gerontol Int; 2022 Oct; 22(10):846-850. PubMed ID: 36058887 [TBL] [Abstract][Full Text] [Related]
22. Cerebral white matter lesions and regional blood flow are associated with reduced cognitive function in early-stage cognitive impairment. Kuroda T; Ono K; Honma M; Asano M; Mori Y; Futamura A; Yano S; Kanemoto M; Hieda S; Baba Y; Izumizaki M; Murakami H Front Aging Neurosci; 2023; 15():1126618. PubMed ID: 36875693 [TBL] [Abstract][Full Text] [Related]
23. A voxel-based morphometric study of cortical gray matter volume changes in Alzheimer's disease with white matter hyperintensities. Ha SY; Youn YC; Kim S; Hsiung GY; Ahn SW; Shin HW; Park KY; Park TH; Kim SS; Kee BS; Kwon OS J Clin Neurosci; 2012 Nov; 19(11):1506-10. PubMed ID: 22989793 [TBL] [Abstract][Full Text] [Related]
24. Volume and Permeability of White Matter Hyperintensity on Cognition: A DCE Imaging Study of an Older Cohort With and Without Cognitive Impairment. Lim C; Lee H; Moon Y; Han SH; Kim HJ; Chung HW; Moon WJ J Magn Reson Imaging; 2024 Oct; ():. PubMed ID: 39425583 [TBL] [Abstract][Full Text] [Related]
25. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease. Chen YF; Wang H; Chu Y; Huang YC; Su MY Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479 [TBL] [Abstract][Full Text] [Related]
26. The association between systolic blood pressure variability with depression, cognitive decline and white matter hyperintensities: the 3C Dijon MRI study. Tully PJ; Debette S; Tzourio C Psychol Med; 2018 Jul; 48(9):1444-1453. PubMed ID: 28950920 [TBL] [Abstract][Full Text] [Related]
27. The Different Associations of White Matter Hyperintensities With Severity of Dementia and Cognitive Impairment According to the Distance From the Lateral Ventricular Surface in Patients With Alzheimer's Disease. Yang HJ; Song JM; Lee S; Lee HK; Kim BS; Kim KW; Park JH Psychiatry Investig; 2024 Aug; 21(8):850-859. PubMed ID: 39111744 [TBL] [Abstract][Full Text] [Related]
28. Effect of vitamin D on cognitive function and white matter hyperintensity in patients with mild Alzheimer's disease. Shih EJ; Lee WJ; Hsu JL; Wang SJ; Fuh JL Geriatr Gerontol Int; 2020 Jan; 20(1):52-58. PubMed ID: 31773862 [TBL] [Abstract][Full Text] [Related]
29. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194 [TBL] [Abstract][Full Text] [Related]
30. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography. Hirao K; Ohnishi T; Matsuda H; Nemoto K; Hirata Y; Yamashita F; Asada T; Iwamoto T Nucl Med Commun; 2006 Feb; 27(2):151-6. PubMed ID: 16404228 [TBL] [Abstract][Full Text] [Related]
31. Impact of atrial fibrillation on the cognitive decline in Alzheimer's disease. Nakase T; Tatewaki Y; Thyreau B; Odagiri H; Tomita N; Yamamoto S; Takano Y; Muranaka M; Taki Y Alzheimers Res Ther; 2023 Jan; 15(1):15. PubMed ID: 36635728 [TBL] [Abstract][Full Text] [Related]
32. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study. Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133 [TBL] [Abstract][Full Text] [Related]
33. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease. Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730 [TBL] [Abstract][Full Text] [Related]
34. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Wolfe N; Reed BR; Eberling JL; Jagust WJ Arch Neurol; 1995 Mar; 52(3):257-62. PubMed ID: 7872878 [TBL] [Abstract][Full Text] [Related]
35. Frontal White Matter Hyperintensity Is Associated with Verbal Aggressiveness in Elderly Women with Alzheimer Disease and Amnestic Mild Cognitive Impairment. Ogama N; Sakurai T; Saji N; Nakai T; Niida S; Toba K; Umegaki H; Kuzuya M Dement Geriatr Cogn Dis Extra; 2018; 8(1):138-150. PubMed ID: 29805380 [TBL] [Abstract][Full Text] [Related]
36. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study. Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042 [TBL] [Abstract][Full Text] [Related]
37. Frontal white matter hyperintensity predicts lower urinary tract dysfunction in older adults with amnestic mild cognitive impairment and Alzheimer's disease. Ogama N; Yoshida M; Nakai T; Niida S; Toba K; Sakurai T Geriatr Gerontol Int; 2016 Feb; 16(2):167-74. PubMed ID: 25613527 [TBL] [Abstract][Full Text] [Related]
38. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort. Prasad K; Wiryasaputra L; Ng A; Kandiah N Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908 [TBL] [Abstract][Full Text] [Related]
39. Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume. van Rooden S; van den Berg-Huysmans AA; Croll PH; Labadie G; Hayes JM; Viviano R; van der Grond J; Rombouts SARB; Damoiseaux JS J Alzheimers Dis; 2018; 66(3):1283-1294. PubMed ID: 30412485 [TBL] [Abstract][Full Text] [Related]
40. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. Matsuda H; Kitayama N; Ohnishi T; Asada T; Nakano S; Sakamoto S; Imabayashi E; Katoh A J Nucl Med; 2002 Mar; 43(3):304-11. PubMed ID: 11884488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]